Tepoxalin
| |
| |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATCvet code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ECHA InfoCard |
100.166.553 |
Chemical and physical data | |
Formula | C20H20ClN3O3 |
Molar mass | 385.844 g/mol |
3D model (JSmol) | |
| |
| |
|
Tepoxalin (brand name Zubrin)[1] is a nonsteroidal anti-inflammatory drug approved for veterinary use in the United States and many other countries.[2] It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.[3]
As of 2017, tepoxalin was not marketed in the United States but still has FDA approval.[1]
References
- 1 2 Papich, Mark G. (2016). "Tepoxalin". Saunders Handbook of Veterinary Drugs Small and Large Animal (4th ed.). Elsevier. p. 762. ISBN 978-0-323-24485-5.
- ↑ https://www.drugs.com/international/tepoxalin.html
- ↑ http://www.peteducation.com/article.cfm?c=26+1303&aid=3213
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.